Made available in DSpace on 2015-04-14T13:35:32Z (GMT). No. of bitstreams: 1 438475.pdf: 1199552 bytes, checksum: 11115a2a9f4a42a185a775b4a566fe5b (MD5) Previous issue date: 2012-03-02 / ADULT (acro-dermato-ungueal-tooth) is a human genetic syndrome that manifests clinically by skin and embryonic appendages anomalies. This syndrome pathogenesis was first identified in 2001, but nowadays it is related to more than one mutation in p63 gene. Although described almost 20 years ago (1993) in Germany, this syndrome still have few reports and this is the first brazilian family. We report here the clinical aspects of five members of a family which clinical features corresponded to phenotypic ADULT manifestations. The clinical aspects included athelia/hypotelia, photosensitivity, dystophic nails, tooth anomalies and lacrimal duct obstruction. The adermatoglyphia, manifestation found in all affected members of this family, was not described before. The histologic examination demonstrated flattening of dermal papillae and electron microsopy showed disrupted collagen fibers. The genetic sequencing of blood ssample found a mutation in p63 gene, already known as R298Q. / A ADULT (acro-dermato-ungueal-lacrimal-tooth) ? uma s?ndrome gen?tica humana que se manifesta clinicamente por altera??es cut?neas e do desenvolvimento dos ap?ndices embrion?rios. Sua etiologia foi identificada inicialmente em 2001, mas atualmente sabe-se que est? relacionada a mais de uma muta??o no gene p63. Apesar de descrita pela primeira vez h? quase duas d?cadas (1993) na Alemanha, a s?ndrome ainda ? pouco reportada e esta ? a primeira fam?lia brasileira descrita. Neste trabalho descrevemos os aspectos cl?nicos de cinco indiv?duos de uma mesma fam?lia, os quais apresentavam manifesta??es fenot?picas compat?veis com a s?ndrome ADULT. Os achados cl?nicos incluem atelia/hipotelia, fotossensibilidade, distrofia ungueal, anormalidades dent?rias e obstru??o do ducto lacrimal. A adermatoglifia, manifesta??o cl?nica demonstrada em todos os acometidos desta fam?lia, n?o fora descrita anteriormente nos portadores da s?ndrome. A avalia??o histol?gica por microscopia ?ptica evidenciou retifica??o das papilas d?rmicas e a an?lise por microscopia eletr?nica mostrou altera??o nas fibras col?genas da derme. O sequenciamento gen?tico atrav?s de amostras de sangue perif?rico identificou uma muta??o no gene p63, previamente conhecida como R298Q.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2018-03-12T15:13:48Z No. of bitstreams: 1 JoaoBatistaFigueredoDeOliveira_DISSERT.pdf: 2360795 bytes, checksum: 9eb1bc700876f6b50145bb832a02c344 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2018-03-15T14:36:30Z (GMT) No. of bitstreams: 1 JoaoBatistaFigueredoDeOliveira_DISSERT.pdf: 2360795 bytes, checksum: 9eb1bc700876f6b50145bb832a02c344 (MD5) / Made available in DSpace on 2018-03-15T14:36:30Z (GMT). No. of bitstreams: 1 JoaoBatistaFigueredoDeOliveira_DISSERT.pdf: 2360795 bytes, checksum: 9eb1bc700876f6b50145bb832a02c344 (MD5) Previous issue date: 2016-01-29 / Esta pesquisa ? uma cartografia, que tem por fundamento as abordagens de Deleuze e Guattari, realizada na Pra?a Mits, na cidade de Natal-RN, composta por juventudes LGBTTI. Nas reflex?es que comp?em o texto, pensamos aquela realidade, como espa?o de pr?ticas n?mades, fazendo uso do conceito de nomadismo formulado por Deleuze e Guattari. Quanto ? constru??o do objeto - ?corpos em muta??es? - ela se deu a partir das leituras de te?ricas/te?ricos e dos efeitos das afeta??es em campo sobre n?s pr?prios. Por essa constru??o, buscamos compreender os corpos como uma amplitude que abriga subjetividade, organismo, multid?o etc., na medida em que ?amos constatando, atrav?s da empiria que, de algum modo, essas dimens?es se atravessam. Utilizamos o termo muta??es, baseados nos relatos e observa??es de campo e focando as transforma??es que as/os jovens se permitem experimentar. A hip?tese norteadora ? que a Pra?a Mits se constitui em um espa?o que possibilita essas muta??es e que favorece a busca por express?es socioculturais das juventudes, que ocupam semanalmente aquele espa?o que, por sua vez, se constitui em um lugar de multiplicidades/diversidades em constantes movimentos de conex?es. / This research is a cartography, which is based in the approaches of Gilles Deleuze and Felix Guattari, developed in the Mits square, situated at Natal-RN city, composed of groups of youngs LGBTTI. Through the reflexions in the text, we think that reality as space of nomad practices, using from the Deleuze and Guattarriconcept of nomadism. About the object's construction ? ?bodies in changing? -it happened by the reading of theorical and of the effects of affectations in camp upon ourselves. By this construction, we try to comprehend the bodies as an amplitude which houses subjectivity, organism, crowd, etc., in that we were finding, by the empirical look that, in someway, these dimensions cross themselves. We use the term "mutation/changing" based on field's reports and observations and focusing the transformations that the young ones allow themselves to experiment. The guiding hypothesis is that the Mits Square constitute a space that allows this changing and encourages the search for social and cultural expressions of youths that weekly engross that space which, in other hand,is constitutedin a place of multiplicities/diversities in constant motion connections.

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2016-09-06T20:24:13Z No. of bitstreams: 1 ThiagoAndreCidral_DISSERT.pdf: 3578139 bytes, checksum: bcb8c85feab01e028e946691a0776a04 (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2016-09-06T23:31:16Z (GMT) No. of bitstreams: 1 ThiagoAndreCidral_DISSERT.pdf: 3578139 bytes, checksum: bcb8c85feab01e028e946691a0776a04 (MD5) / Made available in DSpace on 2016-09-06T23:31:16Z (GMT). No. of bitstreams: 1 ThiagoAndreCidral_DISSERT.pdf: 3578139 bytes, checksum: bcb8c85feab01e028e946691a0776a04 (MD5) Previous issue date: 2016-01-15 / Os Estafilococos Coagulase Negativos (ECN) s?o microrganismos pertencentes ? microbiota normal da pele e de mucosas dos seres humanos e de animais. A maioria das infec??es causadas por ECN est?o relacionadas ao uso de dispositivos m?dicos invasivos que ao lesionar a integridade da pele servem de base para a forma??o de biofilmes, um importante fator de virul?ncia. Grande parte dos isolados de coagulase negativo s?o provenientes de hemoculturas e pontas de cateter e nos ?ltimos anos vem se tornando um grave problema no que diz respeito ? antibioticoterapia, em virtude do n?mero elevado de cepas multirresistentes descritas. O objetivo deste trabalho foi pesquisar resist?ncia ? linezolida em estafilococos coagulase negativos resistentes ? meticilina isolados de ponta de cateter e hemocultura de hospitais p?blicos e privados da cidade do Natal. Os isolados bacterianos foram coletados a partir de demanda espont?nea em Hospitais P?blicos e Privados. O g?nero Staphylococcus foi confirmado atrav?s dos testes de rotina como colora??o de Gram, prova da catalase da coagulase livre. A identifica??o a n?vel de esp?cie foi realizada atrav?s de testes bioqu?micos convencionais. Algumas amostras tiveram sua identifica??o confirmada pelos sistemas VITEK 2 e MALDI-TOF. O perfil de resist?ncia aos antimicrobianos foi avaliado atrav?s da t?cnica de disco-difus?o (CLSI 2013). A Concentra??o Inibit?ria M?nima para vancomicina e linezolida foi determinada atrav?s do uso de E-test e a presen?a dos genes mecA e cfr foi confirmada pela t?cnica da Rea??o em Cadeia da Polimerase. Algumas amostras tiveram a regi?o V da subunidade 23S do gene do rRNA sequenciadas e analisadas. Posteriormente, as mesmas foram submetidas a t?cnica do PFGE para determina??o do seu pulsotipo. Dos 43 estafilococos coagulase negativos resistentes ? oxacilina inclu?dos neste estudo, 33 (77%) foram identificados como S. epidermidis, 6 (14%) como S. haemolyticus, 3 (7%) como S. homins e 1 (2%) como S. capitis. Os isolados de hemocultura representaram 86% (37) e os de ponta de cateter 14% (6). As amostras apresentaram um perfil de multirresist?ncia, uma vez que 42 dos 43 isolados apresentaram resist?ncia ? 4 ou mais classes de drogas. Todas apresentaram o gene mecA. Nenhuma amostra apresentou resist?ncia ? vancomicina. Tr?s cepas de S. hominis e duas de S. epidermidis, apresentaram resist?ncia ? linezolida com CIM variando entre 6 e 64 ?L/mL. Quando investigadas, apresentaram duas muta??es pontuais (C2190T e G2603T) na regi?o V do gene para rRNA 23S. Nenhuma destas apresentou o gene cfr. O PFGE dos S. hominis revelou a presen?a de um ?nico pulsotipo em 3 hospitais, enquanto n?o foi encontrado semelhan?a gen?tica entre os S. epidermidis. Estes achados destacam a import?ncia da vigil?ncia continuada em rela??o a resist?ncia a linezolida no g?nero Staphylococcus. / Coagulase Negative Staphylococci (CoNS) belong to the normal microbiota of the skin and mucous membranes of humans and animals. The most of the infections caused by CoNS are a serious problem, since an elevated number of multi-drug resistant strains. The objective of this study was to investigate resistance to linezolid in methicillin-resistant coagulase negative staphylococci isolates from hospitals in the city of Natal. Bacterial samples were collected from spontaneous demand from Public and Private Hospitals of the city of Natal-RN. The identification staphylococci of the species were conducted by conventional biochemical. Some Samples had the identification to the species level confirmed by automated methodologies VITEK 2? and VITEK MS?. The resistance profile was evaluated with use of the disk diffusion technique (CLSI, 2013). The MIC to vancomycin and linezolid were determined by using E-test method. The antimicrobial resistance profile was evaluated by disk diffusion technique (CLSI 2013). The Minimum Inhibitory Concentration linezolid and vancomycin were determined by using E-test and the presence of the mecA gene and cfr was confirmed by the technique of Polymerase Chain Reaction. Some samples had the V region of the subunit 23S rRNA gene sequenced and subjected to PFGE technique for determining its pulsotype. Of the 43 coagulase negative staphylococci resistant to methicillin included in this study, 33 (77%) were identified as S. epidermidis, 6 (14%) as S. haemolyticus, 3 (7%) as S. homins and 1 (2%) as S. capitis. The catheter tip isolates accounted for 14% (6) and the blood culture 86% (37). Samples showed an alarming resistance profile, since 98% of the isolates were resistant to four or more class drugs. All were positive for mecA gene. No samples were resistant to vancomycin. Three S. hominis and two S. epidermidis exhibited linezolid resistance with MIC ranging from 6 to 64 ?L/mL. None of the samples had the cfr gene. When investigated, they showed two point mutations each (C2190T and G2603T) in the V region of the 23s rRNA gene. None of them was the cfr gene. The S.hominis of PFGE showed the presence of a single pulsotype in three hospitals, suggesting a clonal spread, while it was not found genetic similarity among S. epidermidis. These findings highlight the importance of continued vigilance of linezolid resistance in the genus Staphylococcus.

Made available in DSpace on 2014-12-17T14:16:25Z (GMT). No. of bitstreams: 1 ZamaMLS_DISSERT.pdf: 2983727 bytes, checksum: 7afd93b3940a02c3ef820577c21fb808 (MD5) Previous issue date: 2010-02-25 / Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior / Beta thalassemia arises as a consequence of the reduction (?+, ?++, ?silent) or absence (?0) of beta globin chain synthesis and results from a number of mechanisms that lead to genetic defects. The inheritance of beta thalassemia is characterized by the existence of heterozygous individuals, compound heterozygotes, homozygotes and those with coinheritance of beta thalassemia allele and other thalassemias and/or hemoglobin variants. The aim of this study was to perform molecular and laboratory characterization of beta thalassemia in heterozygous and homozygous individuals and in those with coinheritance of S beta thalassemia. A total of 48 individuals were included (35 heterozygotes, 4 homozygotes and 9 S beta thalessemia carriers) referred to the Integrated Laboratory of Clinical Analyses of the Federal University of Rio Grande do Norte (UFRN) and the Hematology Ambulatory Facility of the Dalton Barbosa Cunha Hemocenter (Hemonorte Natal, Brazil). Peripheral blood samples form each patient underwent the following laboratory examinations: erythrogram, hemoglobin electrophoresis at alkaline pH, measurements of Hb A2, Fetal Hb and serum ferritin. DNA was extracted using the illustra blood genomicPrep Mini Spin Kit and molecular characterization was performed by the PCR/RFLP technique, which involves digestion with specific restriction enzymes for IVS-1 nt 1 (G?A), IVS-1 nt 6 (T?C) and codon 39 (CAG?TAG) mutations. Of the 35 heterozygotes, 37.1% showed IVS-1 nt 6 mutation, 42.9% IVS-1 nt 1 and 20% were carriers of other mutations not identified by the technique used. The four homozygous patients presented with the IVS-1 nt 6 mutation, while 66.7% of the individuals with S beta thalassemia had the IVS-1 nt 1 mutation. Codon 39 was not detected in any of the patients investigated. Of the thallasemic alleles found, 40.4% were IVS- 1 nt 1, 40.4% IVS-1 nt 6 and 19.2% were not identified. Laboratory data showed that the heterozygotes exhibited microcytosis and hypochromia, evidenced by MCV ranging from 57 to 75fL and MCH from 15.9 to 23.6 pg. Hemoglobin A2 varied between 3.7 and 7.2%. The homogygotes also showed reduced MCV and MCH and elevated HbA2.. Comparison of laboratory data between heterozygous individuals with IVS-1 nt 1 and IVS-1 nt 6 mutations showed that heterozygotes for the IVS1-1 mutation had significantly lower mean MCV and MCH (p = 0.023 and 0.007, respectively) and significantly higher hemoglobin A2 (p < 0.001) when compared to heterozygotes for the IVS-1 nt 6 mutation. PCR/RFLP was useful in identifying the presence or absence of IVS-1 nt 6, IVS-1 nt 1 and codon 39 mutations in most of the patients investigated here. This is the first study conducted in the state of Rio Grande do Norte, Brazil aimed at identifying beta thalassemia mutations and represents an important contribution to the knowledge regarding the molecular profile of beta thalassemia in our country / A talassemia beta ocorre devido ? diminui??o (?+, ?++, ?silent) ou aus?ncia (?0) de s?ntese de cadeias beta de globina e ? decorrente de v?rios mecanismos que provocam o defeito gen?tico. A heran?a da talassemia beta ? caracterizada pela exist?ncia de indiv?duos heterozigotos, heterozigoto compostos, homozigotos e portadores de intera??o entre o alelo talass?mico beta e outras talassemias e/ou variantes de hemoglobina. O objetivo principal deste estudo foi realizar a caracteriza??o molecular e laboratorial em indiv?duos heterozigotos e homozigotos da talassemia beta e em portadores da intera??o hemoglobina S/talassemia beta. Foram inclu?dos 48 indiv?duos (35 heterozigotos, 4 homozigotos e 9 com intera??o HbS/talassemia beta) atendidos no Laborat?rio Integrado de An?lises Cl?nicas (UFRN) e no Ambulat?rio de Hematologia do Hemocentro Dalton Barbosa Cunha (Hemonorte Natal/RN). As amostras de sangue perif?rico de cada paciente foram submetidas aos seguintes exames laboratoriais: eritrograma, eletroforese de hemoglobina em pH alcalino, dosagem das hemoglobinas A2 e Fetal, e ferritina s?rica. O DNA foi extra?do utilizando-se o kit blood genomicPrep Mini Spin e a caracteriza??o molecular foi realizada atrav?s da t?cnica PCR/RFLP mediante digest?o com enzimas de restri??o espec?ficas para as muta??es IVS-1 nt 1 (G?A), IVS-1 nt 6 (T?C) e nonsense c?don 39 (CAG?TAG). Dentre os 35 heterozigotos, 37,1% apresentaram a muta??o IVS-1 nt 6, 42,9% a IVS-1 nt 1 e 20% eram portadores de outras muta??es n?o identificadas com a t?cnica utilizada. Os quatro pacientes homozigotos apresentaram a muta??o IVS-1 nt 6, enquanto 66,7% dos indiv?duos com intera??o HbS/talassemia beta tinham a muta??o IVS-1 nt 1. A c?don 39 n?o foi detectada em nenhum dos pacientes investigados. Dentre os alelos talass?micos encontrados, 40,4% eram IVS-1 nt 1, 40,4% eram IVS-1 nt 6 e 19,2% n?o foram identificados. Em rela??o aos dados laboratoriais, os heterozigotos apresentaram microcitose e hipocromia evidenciada pelo VCM variando de 57 a 75fL, e o HCM, entre 15,9 a 23,6 pg. A hemoglobina A2 variou de 3,7 a 7,2%. Os homozigotos tamb?m apresentaram VCM e HCM reduzidos e HbA2 elevada. Ao comparar os dados laboratoriais entre os indiv?duos heterozigotos para as muta??es IVS-1 nt 1 e IVS-1 nt 6 observou-se que os heterozigotos da muta??o IVS1-1 apresentaram valores m?dios de VCM e HCM significativamente menores (p = 0,023 e 0,007, respectivamente) e hemoglobina A2 significativamente mais elevados (p < 0,001) quando comparados aos heterozigotos da muta??o IVS-1 nt 6. A t?cnica de PCR/RFLP se mostrou ?til para a identifica??o da presen?a ou aus?ncia das muta??es IVS-1 nt 6, IVS-1 nt 1 e ?0 c?don 39 na maioria dos pacientes investigados na pesquisa. O presente estudo ? o primeiro trabalho realizado no estado do Rio Grande do Norte para identifica??o das muta??es da talassemia beta, e constitui importante contribui??o para o conhecimento do perfil molecular da talassemia beta em nosso pa?s

Submitted by Automa??o e Estat?stica (sst@bczm.ufrn.br) on 2017-04-17T23:12:48Z No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) / Approved for entry into archive by Arlan Eloi Leite Silva (eloihistoriador@yahoo.com.br) on 2017-04-20T21:54:51Z (GMT) No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) / Made available in DSpace on 2017-04-20T21:54:51Z (GMT). No. of bitstreams: 1 AnaRafaelaDeSouzaTimoteo_TESE.pdf: 3659954 bytes, checksum: d2c8b061166b6be5547b4452cf6fed7b (MD5) Previous issue date: 2016-12-12 / A S?ndrome de c?ncer de mama e ov?rio heredit?rio corresponde a 10-15% de todos os casos diagnosticados de c?ncer de mama no mundo. A maioria das muta??es germinativas s?o identificadas nos genes BRCA1 e BRCA2, contudo, a aplica??o de pain?is multig?nicos tem aumentado o n?mero de variantes patog?nicas detectadas em outros genes supressores de tumor. De acordo com a vers?o atual do protocolo americano NCCN (National Comprehensive Cancer Network), as muta??es em BRCA1 e BRCA2, TP53 e PTEN conferem alto risco de desenvolver c?ncer de mama, e muta??es em CDH1, CHEK2, PALB2, ATM e BRIP podem aumentar em 20% o risco para o desenvolvimento desta doen?a. Neste estudo foram analisados 157 indiv?duos com hist?rico pessoal e/ou familiar de c?ncer de mama. O DNA gen?mico foi isolado a partir de sangue perif?rico por meio de extra??o ? base de solu??o salina e as amostras foram analisadas usando o sequenciamento de nova gera??o (NGS). Foram identificadas 15 variantes patog?nicas e 4 VUS (Variants of Uncertain Significance) em 27 indiv?duos (27/157; 17%), dos quais tr?s s?o assintom?ticos. Foram identificadas sete novas variantes em 4 genes: BRCA1_c.3409A>G; BRCA2_g.26826_30318del, BRCA2_c.5800C>T; BRCA2_c.5228G>A; BRCA2_c.5305delG; ATM_c.634delT e ATR_c.3043C>T. Sessenta e oito por cento (13/19; 68%) de variantes foi detectada nos genes BRCA1 e BRCA2, enquanto 32% (6/19) foram identificados nos genes de risco moderado ATM (2/19); ATR (1/19); CDH1 (1/19); MLH1 (1/19) e MSH6 (1/19). Os indiv?duos foram separados em dois grupos para a an?lise comparativa: portadores de muta??o nos genes de alto risco e nos genes de risco moderado. Entre os tr?s indiv?duos assintom?ticos, duas variantes est?o presentes nos genes de risco moderado ATM e MLH1. Entre os indiv?duos com c?ncer de mama, dezoito pacientes (18/24; 75%) apresentaram muta??es em genes de alto risco, enquanto seis (6/24; 25%) s?o portadores de muta??es em genes de risco moderado. Ambos os grupos apresentaram alta incid?ncia de c?ncer de mama precocemente (83% dos indiv?duos). O grupo de portadores de muta??o nos genes de alto risco apresentaram maior ocorr?ncia de tumores de alto grau (83% vs 67%, P = 0,0090). No grupo de indiv?duos com muta??es em genes de risco moderado, os tumores apresentaram um fen?tipo mais agressivo com c?ncer bilateral (33% versus 11%, P = 0,0002), ocorr?ncia de met?stases (33% vs 5,6%, P <0,0001) e ?bito (33% vs 5,6%, P <0,0001). Ao todo, 1/3 de variantes foram identificadas em genes de risco moderado em pacientes com c?ncer mais agressivo. Estes resultados refor?am a import?ncia da aplica??o de an?lise multig?nica em indiv?duos em situa??o de risco para c?ncer de mama, especialmente em uma popula??o heterog?nea como brasileira. / Hereditary breast and ovarian cancer (HBOC) corresponds to 10-15% of all diagnosed cases of breast cancer in the world. The majority germline mutations are identified in BRCA1 and BRCA2 genes, however the application of multigene panels has increased the number of pathogenic variations detected in DNA repair genes. According to the current version of NCCN (National Comprehensive Cancer Network) Guideline, mutations in BRCA1, BRCA2, TP53 and PTEN confers high risk to develop breast cancer, and mutations in CDH1, CHEK2, PALB2, ATM and BRIP can increases over than 20% this risk. We analyzed 157 individuals with personal and/or familial breast cancer history. Genomic DNA was isolated from peripheral blood through saline-based extraction and samples were analyzed using next-generation sequencing (NGS). We identified 15 pathogenic variants and 4 VUS (Variants of Uncertain Significance) in 27 individuals (27/157; 17%), in which three are asymptomatic. Seven novel variants in 4 genes were identified: BRCA1_c.3409A>G; BRCA2_g.26826_30318del, BRCA2_c.5800C>T; BRCA2_c.5228G>A; BRCA2_c.5305delG; ATM_c.634delT and ATR_c.3043C>T. Sixty-eight percent (13/19; 68%) of variants was detected in BRCA1 and BRCA2 genes, while 32% (6/19) were identified in moderate risk genes ATM (2/19); ATR (1/19); CDH1 (1/19); MLH1 (1/19) and MSH6 (1/19). The individuals were separated in two groups for comparative analysis: high-risk genes and moderate risk genes. Among three asymptomatic individuals, two present variants in moderate risk genes ATM and MLH1. Among breast cancer individuals, eighteen patients (18/24; 75%) presented mutations in high-risk genes, while six (6/24; 25%) harbored mutations in moderate risk genes. Both groups had a high incidence of early-onset breast cancer, 83%. The group of individuals harboring variants in high-risk genes presented a greater occurrence of high-grade tumors (83% vs. 67%, P= 0.0090). In the group of individuals harboring mutation in moderate risk genes, tumors presented a more aggressive phenotype with bilateral cancer (33% vs. 11%, P= 0.0002), occurrence of metastasis (33% vs. 5.6%, P<0.0001) and incidence of deaths (33% vs. 5.6%, P<0.0001). Altogether, 1/3 of variants were identified in moderate risk genes in patients presenting a more aggressive phenotype. These results reinforce the importance of applying multigene analysis in individuals at-risk for breast cancer, especially in a heterogeneous population as Brazilian.